Clinical benefit and cost effectiveness of adding life-time low-dose colchicine as secondary prevention following coronary artery bypass grafting surgery

Clinical benefit and cost effectiveness of adding life-time low-dose colchicine as secondary prevention following coronary artery bypass grafting surgery

Background: Low-dose Colchicine therapy has demonstrated clinical benefit as secondary preventive therapy in patients with chronic coronary artery disease. While prior studies have reported its cost-effectiveness in this patient group, this has not yet been studied in post-coronary artery bypass gra...

Full description

Saved in:
Bibliographic Details
Main Authors: Sai Rahul Ponnana, Gauranga Mahalwar, Joris Holtrop, Steven H.J. Hageman, Tong Zhang, Santosh Kumar Sirasapalli, Skanda Moorthy, Zhuo Chen, Jean-Eudes Dazard, Sadeer Al-Kindi, Yakov Elgudin, Naveed Sattar, Sanjay Rajagopalan, Salil V. Deo
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:American Heart Journal Plus
Online Access:http://www.sciencedirect.com/science/article/pii/S2666602225000837
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2666602225000837

Similar Items